Metoclopramide for women with poor IVF response
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests metoclopramide, a medicine used for certain stomach and nausea conditions, to see if it can improve outcomes for women who have had poor response to IVF. If you fit the “poor ovarian response” definition, you may be eligible after checking the specific exclusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been classified as “poor ovarian response” using the Bologna criteria
- You do not have an allergy to metoclopramide
- You do not have high prolactin levels (prolactinemia)
- You are not currently being treated with dopamine-agonist medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares dydrogesterone with a GnRH antagonist to see which works better for women with a low number of eggs (poor responders) who are undergoing two rounds of egg retrieval in one cycle. It may help improve outcomes for those with specific fertility challenges.
This trial tests whether the common diabetes drug metformin helps improve the lining of the uterus (endometrium) in women with unexplained infertility, which could improve chances of getting pregnant. It might also help you because it is a simple pill with few side effects.
This study tests if metformin, a drug that helps control blood sugar, can improve the chance of a healthy live birth in women with prediabetes who are doing in vitro fertilization (IVF). It aims to see if treating prediabetes before and during early pregnancy leads to better outcomes.
This study tests if adding cabergoline to letrozole works better than letrozole alone to help women with PCOS ovulate. It may help participants who have not had success with standard treatments.
This trial tests a two-phase in-vitro maturation (IVM) method for women under 35 who had poor response to a previous IVF cycle (fewer than 4 eggs retrieved). The goal is to see if this approach helps get more usable eggs and embryos. You would need to freeze all embryos for later transfer.
This trial tests two different ways to trigger the final maturation of eggs before retrieval in women who are considered poor responders to IVF treatment. It aims to see if a double trigger is more effective than the standard HCG trigger for improving egg and embryo outcomes.
Hear when a new Poor Responders in IVF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.